New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide

Haploidentical hematopoietic cell transplantation (haplo‐HCT) with posttransplant cyclophosphamide (PTCY) is utilized for patients with hematological disorders but without conventional donors. The effects of new‐onset posttransplant diabetes mellitus (PTDM) following haplo‐HCT are unknown. We examin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangan, Brendan L., Patel, Dilan, Chen, Heidi, Gatwood, Katie S., Byrne, Michael T., Sengsayadeth, Salyka, Goodman, Stacey, Dholaria, Bhagirathbhai, Kassim, Adetola A., Jagasia, Madan, Chinratanalab, Wichai, Culos, Kathryn A., Engelhardt, Brian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942195/
https://www.ncbi.nlm.nih.gov/pubmed/33709085
http://dx.doi.org/10.1002/jha2.70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942195/
https://www.ncbi.nlm.nih.gov/pubmed/33709085
http://dx.doi.org/10.1002/jha2.70

Ejemplares similares